schizophrenia

Showing 1 - 25 of 2,379

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Schizophrenia Trial (SEP-363856)

Not yet recruiting
  • Schizophrenia
  • (no location specified)
Nov 16, 2022

Schizophrenia Trial in Athens (The combination of the Integrated Psychological Therapy and Metacognitive Training in individuals

Recruiting
  • Schizophrenia
  • The combination of the Integrated Psychological Therapy and Metacognitive Training in individuals with schizophrenia and treatment resistant schizophrenia
  • Athens, Greece
    Stavroula Rakitzi
Nov 14, 2022

Schizophrenia, Negative Symptoms in Schizophrenia, Cognitive Impairment Trial in Shanghai (Bilateral Active Repetitive

Recruiting
  • Schizophrenia
  • +4 more
  • Bilateral Active Repetitive transcranial magnetic stimulation (rTMS)
  • +2 more
  • Shanghai, Shanghai, China
    Shanghai Xuhui Mental Health Center
Oct 25, 2022

Schizophrenia Trial in Shanghai (rTMS and MEG for auditory hallucinations via single arm)

Recruiting
  • Schizophrenia
  • rTMS and MEG for auditory hallucinations via single arm
  • Shanghai, China
    Shanghai Mental Health Center
Oct 25, 2022

Schizophrenia, Schizoaffective Disorder, Mixed Type, Negative Symptoms in Schizophrenia Trial in Taipei (HD-tDCS)

Recruiting
  • Schizophrenia
  • +2 more
  • HD-tDCS
  • Taipei, Taiwan
    Tri-service general hospital
Oct 18, 2022

Schizophrenia Trial in Toronto (Non-invasive brainstem modulation device (stimulation Randomized), Non-invasive brainstem

Not yet recruiting
  • Schizophrenia
  • Non-invasive brainstem modulation device (stimulation Randomized)
  • Non-invasive brainstem modulation device (stimulation-Open Label)
  • Toronto, Ontario, Canada
    Centre for Addiction and Mental Health
Oct 13, 2022

Schizophrenia, Psychosis Trial in Kingston (Self-stigma intervention)

Enrolling by invitation
  • Schizophrenia
  • Psychosis
  • Self-stigma intervention
  • Kingston, Ontario, Canada
    Queen's University
Oct 4, 2022

Schizophrenia, Schizoaffective Disorder, Prodromal Schizophrenia Trial in Boston (repetitive Transcranial Magnetic Stimulation

Not yet recruiting
  • Schizophrenia
  • +2 more
  • repetitive Transcranial Magnetic Stimulation (rTMS)
  • Boston, Massachusetts
    Beth Israel Deaconess Medical Center
Oct 1, 2022

Schizophrenia Trial (Metacognitive Group Intervention, Occupational therapy standard care)

Completed
  • Schizophrenia
  • Metacognitive Group Intervention
  • Occupational therapy standard care
  • (no location specified)
Sep 29, 2022

Using Speech to Monitor Symptom Severity in Arabic Speaking

Recruiting
  • Schizophrenia
  • WinterLight Mobile Phone Speech Analysis
  • Algiers, Algeria
  • +3 more
Sep 28, 2022

Schizophrenia Trial (NBI-1117568, Placebo)

Not yet recruiting
  • Schizophrenia
  • (no location specified)
Sep 14, 2022

Schizophrenia Trial in Shanghai (Transcranial Magenetic Stimulation, Sham Transcranial Magenetic Stimulation)

Recruiting
  • Schizophrenia
  • Transcranial Magenetic Stimulation
  • Sham Transcranial Magenetic Stimulation
  • Shanghai, Shanghai, China
    Shanghai Pudong New Area Mental Health Center
Sep 13, 2022

Schizophrenia Trial (SEP-363856, Prior antipsychotic (risperidone, olanzapine, quetiapine or aripiprazole))

Not yet recruiting
  • Schizophrenia
  • SEP-363856
  • Prior antipsychotic (risperidone, olanzapine, quetiapine or aripiprazole)
  • (no location specified)
Sep 13, 2022

Psychosis, Schizophrenia, Schizo Affective Disorder Trial in Minneapolis (BrainHQ Computerized Cognitive Training - Visual

Recruiting
  • Psychosis
  • +9 more
  • BrainHQ Computerized Cognitive Training - Visual Perception Training Paradigm
  • BrainHQ Computerized Cognitive Training - Visual Cognitive Control Training Paradigm
  • Minneapolis, Minnesota
    University of Minnesota
Sep 9, 2022

Schizophrenia Trial in New Haven (Musical Intervention)

Completed
  • Schizophrenia
  • Musical Intervention
  • New Haven, Connecticut
    Department of Psychiatry, Yale School of Medicine
Sep 8, 2022

PET Scanning in Parkinson s Disease

Recruiting
  • Schizophrenia
  • Parkinson's Disease
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Aug 24, 2022

    Functional Relevance of Dopamine Receptors in Healthy Controls

    Recruiting
    • Schizoaffective Disorder
    • Schizophrenia
      • Bethesda, Maryland
        National Institutes of Health Clinical Center, 9000 Rockville Pi
      Aug 24, 2022

      Schizophrenia Trial in Moscow, Stavropol' (VLT-015)

      Recruiting
      • Schizophrenia
      • Moscow, Moscow Region, Russian Federation
      • +1 more
      Aug 22, 2022

      Schizophrenia Trial in Worldwide (BI 425809, Placebo)

      Recruiting
      • Schizophrenia
      • BI 425809
      • Placebo
      • Little Rock, Arkansas
      • +72 more
      Aug 24, 2022

      Schizophrenia Trial in Worldwide (Placebo, AVP-786)

      Recruiting
      • Schizophrenia
      • Little Rock, Arkansas
      • +81 more
      Aug 23, 2022

      Schizophrenia Trial in United States (CT-155 smartphone app)

      Enrolling by invitation
      • Schizophrenia
      • CT-155 smartphone app
      • Culver City, California
      • +9 more
      Aug 18, 2022

      Tobacco Use, Tobacco Smoking, Tobacco Use Cessation Trial in New Brunswick (Persistence Targeted Smoking Cessation in SMI

      Completed
      • Tobacco Use
      • +5 more
      • Persistence Targeted Smoking Cessation in SMI (PTSC-S)
      • Nicotine patch
      • New Brunswick, New Jersey
        Division of Addiction Psychiatry
      Aug 18, 2022

      Magnetic Resonance Imaging of Neuropsychiatric Patients and

      Recruiting
      • Schizophrenia
      • Normal Physiology
        • Bethesda, Maryland
          National Institutes of Health Clinical Center, 9000 Rockville Pi
        Aug 18, 2022

        Schizophrenia, Schizoaffective, Cognition Trial in Los Angeles (Cognitive Training)

        Active, not recruiting
        • Schizophrenia
        • +2 more
        • Cognitive Training
        • Los Angeles, California
          View Heights Convalescent Hospital
        Aug 16, 2022

        Schizophrenia, Cannabis Use Trial in London (Cannabidiol, Placebo, Delta-9-THC)

        Recruiting
        • Schizophrenia
        • Cannabis Use
        • London, United Kingdom
          South London and Maudsley NHS Foundation Trust
        Aug 16, 2022